Emergent BioSolutions Inc. (ER4)
FSX
Closed
Oct 9, 2026
Day's Range
6.0452 wk Range
3.81Overview - ER4 - Emergent BioSolutions Inc.
Key Statistics
Valuation
Enterprise Value
653.22M
P/E (Trailing)
‪8.79‬
P/E (Forward)
‪1.12‬
PEG Ratio
‪0.0059‬
Price / Sales (TTM)
‪0.38‬
Price / Book
‪1.01‬
EV / EBITDA
‪3.20‬
Profitability
Gross Margin
‪57.18%‬
Profit Margin
‪-22.95%‬
Operating Margin
‪28.34%‬
Return on Assets
‪6.93%‬
Return on Equity
‪-40.29%‬
Ownership
Shares Outstanding
51.30M
Float
49.06M
Held by Insiders
‪4.25%‬
Held by Institutions
‪90.73%‬
Price stats
Beta
‪2.33‬
50-Day Avg
‪5.34‬
200-Day Avg
‪7.38‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - ER4 - Emergent BioSolutions Inc.
Peers - ER4 - Emergent BioSolutions Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on FSX.
- ER4FSXEmergent BioSolutions Inc.301.99MMarket Cap-28.69%52-week change8.80P/E (Trailing)‪-22.95%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- PARFSXParker-Hannifin Corporation109.81BMarket Cap+26.04%52-week change35.40P/E (Trailing)‪16.96%‬Profit Margin
- MRKFSXMerck KGaA60.08BMarket Cap+13.03%52-week change25.79P/E (Trailing)‪11.21%‬Profit Margin
- MRKCFSXMerck KGaA – Sponsored ADR58.69BMarket Cap+14.60%52-week change24.77P/E (Trailing)‪11.21%‬Profit Margin
- PY3FSXGalderma Group AG39.87BMarket Cap-1.16%52-week change54.63P/E (Trailing)‪14.57%‬Profit Margin
- 0BOFSXJiangsu Hengrui Pharmaceuticals Co., Ltd.37.83BMarket Cap-75.44%52-week change37.67P/E (Trailing)‪24.93%‬Profit Margin
Profile Summary - ER4 - Emergent BioSolutions Inc.
About
Emergent BioSolutions Inc. is a global life sciences company that primarily focuses on the development, manufacturing, and distribution of a wide array of medical products. These products are designed to address public health threats including chemical and biological agents, and infectious diseases. As an important…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
